AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat
BREAKING: Futures Mixed Amid Earnings Movers; Elon Musk Pay Vote DueAstraZeneca (AZN) stock popped early Thursday after the pharma company reported earnings of 15.19 billion in third-quarter sales.On average, analysts polled by FactSet expected AstraZeneca to earn 14.78 billion in sales. Revenue from cancer drugs jumped 19% to $6.64 billion. The oncology division accounted for 44% of total sales in the third quarter.During the year-earlier period, AstraZeneca ea ...